BIOT:SW L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF

CHF 8.59 0.14 1.692107
Icon

L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (BIOT:SW) Stock Analysis and Price Targets

ETF | Others | SW
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CHF 8.59

+0.14 (+1.69)%

N/A

N/A

N/A

N/A

Icon

BIOT:SW

L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (CHF)
ETF | SW
CHF 8.59
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

CHF 8.59

L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (BIOT:SW) Stock Forecast

N/A

Based on the L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF stock forecast from 0 analysts, the average analyst target price for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF is not available over the next 12 months. L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF’s stock price was CHF 8.59. L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF’s stock price has changed by +0.53% over the past week, -2.55% over the past month and -14.62% over the last year.

No recent analyst target price found for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF
No recent average analyst rating found for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF

Company Overview L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF

NA

N/A

N/A

N/A

N/A

CHF

Switzerland

N/A

N/A

N/A

N/A

Adjusted Closing Price for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (BIOT:SW)

Loading...

Unadjusted Closing Price for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (BIOT:SW)

Loading...

Share Trading Volume for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF Shares

Loading...

Compare Performance of L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIOT:SW

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • N/A

  • 0%

Stocks Similar To L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (Sector: Others )

Symbol Name Mer Price(Change) Market Cap
CHSRIA:SW
UBS ETF (CH) MSCI Switzerland .. 0.00 % -0.20 (-0.99%) CHF492,935.36B

ETFs Containing BIOT

Symbol Name BIOT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (BIOT:SW) Stock

Stock Target Advisor's fundamental analysis for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's stock is Very Bearish.

BIOT:SW stock's dividend yield is 0.94%. Our analysis grades BIOT:SW stock's dividend yield at F. This means that BIOT:SW stock's dividend yield is above 8% of the stocks in the Others sector in the SW exchange. Based on this BIOT:SW may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on BIOT:SW's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIOT:SW's stock to indicate if its overvalued.

The last closing price of BIOT:SW's stock was CHF 8.59.

Unfortunately we do not currently have any market capitalization data for BIOT:SW's stock.

Unfortunately we do not have enough analyst data on BIOT:SW's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's stock.

Sorry, we do not have any data on the number of employees for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF.

Sorry we do not have any infomation available on L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...